Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Philippe Morinière

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Renal Dialysis

Chemicals & Drugs

Disorders

Anatomy

Bone and Bones

Concepts & Ideas

Risk Factors

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Monge Matthieu; Shahapuni Irina; Oprisiu Roxana; El Esper Najeh; Morinière Philippe; Massy Ziad; Choukroun Gabriel; Fournier Albert
Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
Shahapuni Irina; Monge Matthieu; Oprisiu Roxana; Mazouz Hakim; Westeel Pierre-François; Morinière Philippe; Massy Ziad; Choukroun Gabriel; Fournier Albert
Drug Insight: renal indications of calcimimetics.
Monge Matthieu; Shahapuni Irina; Harbouche Laïd; Morinière Philippe; Esper Najeh El; Massy Ziad; Choukroun Gabriel; Fournier Albert
Cinacalcet and vascular calcifications induced by calcitriol.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Philippe Morinière (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2006: Monge Matthieu; Shahapuni Irina; Oprisiu Roxana; El Esper Najeh; Morinière Philippe; Massy Ziad; Choukroun Gabriel; Fournier Albert
Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
Nature clinical practice. Nephrology 2006;2(6):326-36.
2006: Shahapuni Irina; Monge Matthieu; Oprisiu Roxana; Mazouz Hakim; Westeel Pierre-François; Morinière Philippe; Massy Ziad; Choukroun Gabriel; Fournier Albert
Drug Insight: renal indications of calcimimetics.
Nature clinical practice. Nephrology 2006;2(6):316-25.
2006: Monge Matthieu; Shahapuni Irina; Harbouche Laïd; Morinière Philippe; Esper Najeh El; Massy Ziad; Choukroun Gabriel; Fournier Albert
Cinacalcet and vascular calcifications induced by calcitriol.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(2):551-2.
2003: Ghazali Abderrahmane; Grados Franck; Oprisiu Roxana; Bunea Delia; Morinière Philippe; El Esper Najeh; El Esper Isabelle; Brazier Michel; Souberbielle Jean Claude; Fournier Albert; Thomas Thierry
Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(9):1882-90.
2001: Fournier A; Oprisiu R; Mazouz H; Morinière P; El Esper N; Choukroun G
Low parathyroid hormone levels and higher risk of hip fractures and mortality.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(1):222-4.
2001: Fournier A; Cohen Solal M E; Oprisiu R; Choukroun G; Morinière P H; Bouillon R
7-84 PTH or aluminum antagonism in the resistance of uremic bone to the remodeling effect of endogenous PTH?
Kidney international 2001;59(6):2375-6.
2000: Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
[Renal osteodystrophy (3); its treatment in dialysis patients]
Néphrologie 2000;21(8):413-24.
2000: Hottelart C; Bako G; Oprisiu R; Georgita A; Presne C; Sarraj A; Morinière P; el Esper N; Fournier A
[Renal osteodystrophy (2): its treatment in renal insufficiency before dialysis]
Néphrologie 2000;21(6):275-82.
2000: Oprisiu R; Hottelart C; Ghitsu S; Said S; Westeel P F; Morinière P; el Esper N; Pruna A; Fournier A
[Renal osteodystrophy (1): invasive and non-invasive diagnosis of its pathologic varieties]
Néphrologie 2000;21(5):229-37.
1999: Hardy P; Morinière P H; Tribout B; Hamdini N; Marié A; Bouffandeau B; Pruna A; Fournier A
Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients.
Journal of nephrology 1999;12(6):398-403.
1999: Ghazali A; Fardellone P; Pruna A; Atik A; Achard J M; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
Kidney international 1999;55(6):2169-77.
1999: Fournier A; Fardellone P; Achard J M; Ghazali A; Pruna A; El Esper N; Morinière P
Importance of vitamin D repletion in uraemia.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(4):819-23.
1999: Fournier A; Morinière P; Pruna A
The care of patients undergoing hemodialysis.
The New England journal of medicine 1999;340(9):736; author reply 736-7.
1999: Séchet A; Abighanem O; Said S; Rasombololona M; Morinière P; Brazier M; Fournier A
[Inhibition of gastric secretion by omeprazole and efficacy of calcium carbonate in the control of hyperphosphatemia in patients on maintenance hemodialysis]
Néphrologie 1999;20(4):213-6.
1999: Séchet A; Abighanem O; Said S; Rasombololona M; Morinière P; Brazier M; Fournier A
[Role of the time of administration of calcium carbonate (before or during mealtime) in the control of hyperphosphatemia in patients on maintenance hemodialysis]
Néphrologie 1999;20(4):209-12.
1999: Kacso I; Gherman M; Mazouz H; Ghazali A; el Esper N; Morinière P; Makdassi R; Hardy P; Westeel P F; Achard J M; Pruna A; Fournier A
[Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis]
Néphrologie 1999;20(1):19-28.
1998: Vautier-Rodary R; Filloux-Morfaux V; Morinière P; Fournier A; Remond A
[Percutaneous recanalization of proximal venous thromboses in chronic hemodialysis patients]
Journal de radiologie 1998;79(3):253-7.
1997: Morinière P; Rodary-Vautier R; Fillioux-Morfaux V; Dehouck B; el Esper N; Remond A; Fournier A
Percutaneous recanalization of occlusion of central and proximal veins in chronic hemodialysis. Technical note.
Kidney international 1997;52(5):1406-11.
1997: Fournier A; Oprisiu R; Said S; Sechet A; Ghazali A; Marié A; el Esper I; Brazier M; Achard J M; Morinière P
Invasive versus non-invasive diagnosis of renal bone disease.
Current opinion in nephrology and hypertension 1997;6(4):333-48.
1997: Fournier A; Hardy P; Yverneau; Morinière P; Achard J M
The set point of calcium-regulated PTH secretion as assessed in vivo: a physiological or artificial concept?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(6):1302-3.
1997: Fournier A; Achard J M; Morinière P
Chronic metabolic correction in haemodialysed patients actually has a direct suppressive effect on PTH secretion. Another view of published data.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(3):627.
1997: Fournier A; Oprisiu R; el Esper N; Morinière P
Is oral intermittent calcitriol more effective than daily calcitriol therapy in suppressing overt secondary hyperparathyroidism in predialysis patients?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(2):365-7.
1997: Fournier A; Said S; Ghazali A; Sechet A; Ezaitouni F; Marie A; Westeel P F; Morinière P; Boudailliez B
The clinical significance of adynamic bone disease in uremia.
Advances in nephrology from the Necker Hospital 1997;27():131-66.
1997: Atik A; Ghazali A; Achard J M; Rida Z; Oprisiu R; Brazier M; Leflon P; Gueris J; Morinière P; Sari Z; Fournier A
[Relative depletion in native vitamin D: a potential risk factor in Algerian hemodialysis patients with radiological evidence of hyperparathyroidism and osteomalacia independent of calcitriolemia]
Néphrologie 1997;18(2):47-52.
1995: Fournier A; Oprisiu R; El Esper N; Morinière P h
Optimal plasma concentrations of intact parathyroid hormone in predialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(12):2376-8.
1995: Fournier A; Morinière P H; Oprisiu R; Yverneau-Hardy P; Westeel P F; Mazouz H; el Esper N; Ghazali A; Boudailliez B
1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.
Nephron 1995;71(3):254-83.
1995: Fournier A; Morinière P; Yverneau-Hardy P; Westeel P F; Mazouz H; el Esper N; Ghazali A; Boudailliez B
[Vitamin D treatment and renal osteodystrophy: indications and modalities]
Néphrologie 1995;16(2):165-90.
1995: Fournier A; Morinière P; Marié A
Adynamic bone disease--is it actually a disease?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(4):454-7.
1994: Dupont D; Morinière P; Pourchez T; el Esper N; Fournier A
[Long-term development of Permacath Quinton catheters used as a vascular access route for extra-renal detoxification]
Néphrologie 1994;15(2):105-10.
1994: Ben Hamida F; Ghazali A; Boudzernidj M; Amar M; Morinière P; Westeel P; Fournier A
[Hyperparathyroidism secondary to renal insufficiency. Physiopathology, clinicoradiological aspects and treatment]
Annales d'endocrinologie 1994;55(5):147-58.
1993: Cohen-Solal M E; Sebert J L; Morinière P; Fournier A
[Adynamic bone disease in kidney failure. Role of aluminum]
Revue du rhumatisme (Ed. française : 1993) 1993;60(5):361-4.
1993: Ben Hamida F; el Esper I; Compagnon M; Morinière P; Fournier A
Long-term (6 months) cross-over comparison of calcium acetate with calcium carbonate as phosphate binder.
Nephron 1993;63(3):258-62.
1992: Fournier A; Morinière P; Ben Hamida F; el Esjer N; Shenovda M; Ghazali A; Bouzernidj M; Achard J M; Westeel P F
Use of alkaline calcium salts as phosphate binder in uremic patients.
Kidney international. Supplement 1992;38():S50-61.
1992: Morinière P; Djerad M; Boudailliez B; el Esper N; Boitte F; Westeel P F; Compagnon M; Brazier M; Achard J M; Fournier A
Control of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate. Comparable efficacy for half the dose of elemental calcium given as acetate without lower incidence of hypercalcemia.
Nephron 1992;60(1):6-11.
1992: Cohen-Solal M E; Sebert J L; Boudailliez B; Westeel P F; Morinière P H; Marie A; Garabedian M; Fournier A
Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?
Bone 1992;13(1):1-5.
1991: Morinière P; Boudailliez B; Westeel P F; Achard J M; Djerad M; Nahle M; Amar M; Fournier A
[Role of calcium carbonate in the treatment of renal osteodystrophy]
Néphrologie 1991;12(1):31-41.
1991: Fournier A; Morinière P; Cohen Solal M E; Boudailliez B; Achard J M; Marie A; Sebert J L
Adynamic bone disease in uremia: may it be idiopathic? Is it an actual disease?
Nephron 1991;58(1):1-12.
1991: Morinière P; Marie A; el Esper N; Fardellone P; Deramond H; Remond A; Sebert J L; Fournier A
Destructive spondyloarthropathy with beta 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis.
Nephron 1991;59(4):654-7.
1991: Djerad M; Morinière P; Westeel P F; el Esper N; Boitte F; Morsli R; Schenouda M; Compagnon M; Achard J M; Fournier A
[Comparison of calcium acetate and calcium carbonate for the control of predialysis hyperphosphatemia]
Néphrologie 1991;12(4):193-7.
1990: Leflon P; Plaquet R; Morinière P; Fournier A
Determination of aluminum in bone in haemodialyzed patients, using inductively coupled argon plasma emission spectrometry.
Clinica chimica acta; international journal of clinical chemistry 1990;191(1-2):31-8.
1990: Diéval J; Morinière P; Gross S; d'Azemar P; Fournier A; Delobel J
Influence of thromboembolism prophylaxis by low molecular weight heparin CY 216 (Fraxiparine) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216.
Thrombosis research 1990;58(6):555-60.
1990: Belbrik S; Marie A; Boudailliez B; Morinière P; Sébert J L; Solal M C; Westeel P F; Roche D; Fournier A
[Prevalence of histological types of bone disease in a hemodialysis center limiting the oral intake of aluminum hydroxide]
Néphrologie 1990;11(2):83-90.
1990: Morinière P; Diéval J; Roussel B; Gross S; Bayrou B; Delobel J; Fournier A
[Parameters of hemostasis during treatments associating fractionated heparin administered subcutaneously to standard and fractionated heparin administered intravenously in the chronic hemodialysis patient]
Néphrologie 1990;11(3):141-6.
1989: Lalau J D; Andrejak M; Morinière P; Coevoet B; Debussche X; Westeel P F; Fournier A; Quichaud J
Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.
International journal of clinical pharmacology, therapy, and toxicology 1989;27(6):285-8.
1989: Morinière P; Cohen-Solal M; Belbrik S; Boudailliez B; Marie A; Westeel P F; Renaud H; Fievet P; Lalau J D; Sebert J L
Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum.
Nephron 1989;53(2):93-101.
1989: Fournier A; Boudailliez B; Westeel P F; Morinière P; Idrissi A; Belbrik S; Hocine C; Marie A; Cohen Solal M E
Prevention of secondary hyperparathyroidism in chronic renal failure before dialysis.
Contributions to nephrology 1989;71():64-80.
1989: Pourchez T; Morinière P; Fournier A; Pietri J
Use of Permcath (Quinton) catheter in uraemic patients in whom the creation of conventional vascular access for haemodialysis is difficult.
Nephron 1989;53(4):297-302.
1989: Morinière P; Dieval J; Bayrou B; Roussel B; Renaud H; Fournier A; Delobel J
Low-molecular-weight heparin Fraxiparin in chronic hemodialysis. A dose-finding study.
Blood purification 1989;7(6):301-8.
1989: Morinière P; Boudailliez B; Hocine C; Belbrik S; Renaud H; Westeel P F; Solal M C; Fournier A
Prevention of osteitis fibrosa, aluminium bone disease and soft-tissue calcification in dialysis patients: a long-term comparison of moderate doses of oral calcium +/- Mg(OH)2 vs Al(OH)3 +/- 1 alpha OH vitamin D3.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1989;4(12):1045-53.
1988: Fournier A; Morinière P; Boudailliez B; Marie A; Westeel P F; Renaud M; Belbrik S; Hocine C; Sebert J L
[High doses of calcium carbonate or the combination of 1 alpha hydroxylated derivatives of vitamin D and aluminum compounds bound to phosphorus in the preventive treatment of renal osteodystrophy]
Presse médicale (Paris, France : 1983) 1988;17(16):777-80.
1988: Fournier A; Morinière P; Renaud H
The approach to the treatment of secondary hyperparathyroidism in early renal failure.
American journal of nephrology 1988;8(2):170-2.
1988: Renaud H; Atik A; Hervé M; Morinière P; Hocine C; Belbrik S; Fournier A
Evaluation of vascular calcinosis risk factors in patients on chronic hemodialysis: lack of influence of calcium carbonate.
Nephron 1988;48(1):28-32.
1988: Demontis R; Reissi D; Noël C; Morinière P; Renaud H; Leflon P; Westeel P F; Brasseur J; Coevoet B; Fournier A
[Indirect evaluation of the effect of 1 alpha-hydroxyvitamin D3 on intestinal absorption of aluminum]
Néphrologie 1988;9(3):135-8.
1988: Morinière P; Vinatier I; Westeel P F; Cohemsolal M; Belbrik S; Abdulmassih Z; Hocine C; Marie A; Leflon P; Roche D
Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1988;3(5):651-6.
1988: Morinière P; Fournier A; Westeel P F; Idrissi A; Renaud H; Hocine C; Belbrik S; Marie A; Leflon P; Sebert J L
Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experience.
Contributions to nephrology 1988;64():58-73.
1988: Renaud H; Fournier A; Morinière P; Westeel P F; Marie A; Sebert J L
[Multifocal osteoarthropathy associated with beta-2 microglobulin amylosis deposit in a patient with renal insufficiency treated exclusively with hemofiltration]
Néphrologie 1988;9(2):89-90.
1987: Sebert J L; Ruiz J C; Fournier A; Fardellone P; Guéris J; Marié A; Morinière P; Codet M P; Renaud H
Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patients.
Bone and mineral 1987;2(1):21-7.
1987: Abdulmassih Z; Duverlie G; Morinière P; Atik A; Hannoun C; Henrotte J G; Daniel P; Fournier A
[Response to influenza vaccine in uremic patients: relation to erythrocyte magnesium and the value of a second injection]
Néphrologie 1987;8(1):23-6.
1987: Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J
[Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage]
Journal des maladies vasculaires 1987;12 Suppl B():114-8.
1986: Sebert J L; Fournier A; Leflon P; Fohrer P; de Frémont J F; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
Nephron 1986;42(1):34-40.
1985: Morinière P; Fournier A; Leflon A; Hervé M; Sebert J L; Grégoire I; Bataille P; Guéris J
Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.
Nephron 1985;39(4):309-15.
1984: Dubois N; Fievet E; Fievet P; Morinière P; Ringot P L; De Sommer-Leroy R; Fournier A; Pietri J
[Monitoring therapeutic arteriovenous fistulas in chronic hemodialysis patients. Value of the continuous Doppler test combined with real-time echotomography]
Journal des maladies vasculaires 1984;9(3):211-4.
1983: Tyan P; Deramond H; Morinière P; Delamarre J; De Frémont J F; Fournier A; Trinez G
[Real-time ultrasonographic study of the parathyroid glands. Apropos of 100 explorations]
Journal de radiologie 1983;64(8-9):465-9.
1983: Westeel P F; Coevoet B; Bens J L; Neuville M; Morinière P; Fievet P; Dkhissi H; Fournier A
[Blood gas and acid-base changes and rhythmologic tolerance of acetate and bicarbonate hemodialysis using a standard dialyser with high sodium and control of ultrafiltration]
Néphrologie 1983;4(4-5):194-9.
1982: Sebert J L; Decourcelles P H; Morinière P; Calmette C; Gueris J; Makdassi R; Khassouf J; Andrejak M; Fournier A
Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretion.
Mineral and electrolyte metabolism 1982;8(6):293-9.
1982: Makdassi R; Andrejak M; Morinière P; Sebert J L; Decourt S; Guéris J; Coevoet B; Fournier A
Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremia.
Advances in experimental medicine and biology 1982;151():667-76.
1982: de Fremont J F; Morinière P; Pruna A; Gheerbrandt J D; Kassouf J; Roussel A; Galy C; Fournier A
Long-term evaluation of hemofiltration at home.
Contributions to nephrology 1982;32():119-27.
1982: Sebert J L; Fournier A; Lambrey G; Morinière P; Decourcelle P H; Makdassi R; De Frémont J F
[Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?]
Néphrologie 1982;3(3):133-41.
1980: de Frémont J F; Lambrey G; Gheerbrant J D; Coevoet B; Morinière P; Fournier A
[Home hemofiltration: 2 year's experience]
La Nouvelle presse médicale 1980;9(28):1961.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Philippe Morinière

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Philippe Morinière (preview)

All Publications